ESCs/iPSCs

Researchers describe how a new “universal” strategy for CRISPR-Cas9-mediated gene correction in patient derived stem cells may represent a promising therapeutic option

Researchers describe how modulating glycan-mediated growth factor association and signaling can maintain mESCs in a pluripotent state

Researchers describe a robust and simple means to assess quality control in cultures of human embryonic stem cell cultures: intact cell mass spectrometry fingerprinting

New comparative study highlights the utility of human pluripotent stem cell-derived organoids in studies of kidney development and kidney disease

A new study delineates the role of the tumor-related transcription factor Gabpa in the pluripotency network of mouse embryonic stem cells

A new study employs patient samples to develop a new induced pluripotent stem cell model of the dry form of age-related macular degeneration, a common cause of blindness

Researchers have improved the differentiation of RGCs by creating a new and improved reporter human ESC line generated via CRISPR/Cas9 genome editing 

A new study suggests that engineered antibodies may facilitate the delineation of pluripotency networks and could represent the future of reprogramming approaches 

A study shows how human pluripotent stem cells form functional osteoblasts following transplantation into a mouse embryo engineered to lack a skeletal system

Researchers investigating sex chromosome trisomy discover that reprogramming patient cell samples may be an effective means to treat human infertility